In the first set of experiments, C57BL/6 mice were implanted intracranially with GSC-005 murine glioma cells and randomly assigned to receive treatment with Delta-24-RGDOX or the immunomodulatory IDO inhibitor indoximod (Figure 1A).24 The gene discussed is IDO1; the disease is central nervous system cancer.